Target intelligence / Profile preview

ATP synthase membrane subunit k, mitochondrial (ATP5MK)

Target
ATP5MK
Molecular classification
Enzyme subunit, ATP synthase complex component (F₀ membrane sector subunit), Mitochondrial membrane protein, Other (described as "diabetes-associated protein in insulin-sensitive tissues" based on expression pattern)
01

Overview

ATP synthase membrane subunit k (ATP5MK) is a small, highly conserved protein within the F₀ subunit of the mitochondrial ATP synthase complex that is embedded in the inner mitochondrial membrane. ATP synthase is a large multimeric enzyme responsible for synthesizing ATP from ADP and inorganic phosphate during oxidative phosphorylation. Subunit k (also known as DAPIT) is involved in the assembly, stability, and structural integrity of the ATP synthase complex, including the formation of ATP synthase dimers that are essential for proper cristae morphology in mitochondria. Dysregulation or mutation of ATP5MK/DAPIT has been associated with altered energy metabolism and implicated in certain pathologies, including diabetes and muscular disorders. Although subunit k itself is not currently a direct therapeutic target, its role in disease mechanisms and as a potential biomarker is of growing research interest[2][3][4].

Other names
ATP5MKATP synthase F(0) complex subunit k, mitochondrialDAPITATP5MDHCVFTP2USMG5Up-regulated during skeletal muscle growth protein 5Diabetes-associated protein in insulin-sensitive tissuesHCV F-transactivated protein 2AGPbA792D24.4
02

Mechanism of action

Not established for subunit k alone For the entire ATP synthase complex: inhibitors bind F₀ sector and block proton translocation, inhibiting ATP synthesis

03

Biological functions

Cellular energy production (ATP synthesis)Proton transport across mitochondrial inner membraneMitochondrial cristae formation (contributes to structure and dimerization of ATP synthase complexes)[2]
04

Disease associations

Diabetes (as reflected by aliases and expression studies)Mitochondrial diseasesMuscle development disorders (based on its increased expression during muscle growth)Potential links to cardiovascular and neurodegenerative disorders, but evidence is limited and emerging
05

Safety considerations

General risks associated with ATP synthase inhibition: severe impairment of cellular energy production, mitochondrial dysfunction, and cytotoxicityNo subunit k-specific clinical safety data; anticipated risks follow from the complex's critical role in bioenergetics
06

Biomarkers

Altered expression (up- or downregulation) of ATP5MK/DAPIT may serve as a biomarker for muscle growth or diabetes in experimental contexts

Beyond the preview

Go deeper on ATP synthase membrane subunit k, mitochondrial (ATP5MK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase membrane subunit k, mitochondrial (ATP5MK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call